Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma

OBJECTIVE: Somatic TP53 mutation (TP53(mut)) is a characteristic finding in high-grade serous ovarian cancer (HGSOC). The aim of this study was to assess the clinical efficacy and utility of TP53(mut) circulating tumor DNA (ctDNA) monitoring as a biomarker for managing HGSOC. METHODS: TP53(muts) wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong-Man, Lee, Shin-Wha, Lee, Young-Jae, Lee, Ha-Young, Lee, Jong-Eun, Choi, Eun-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424844/
https://www.ncbi.nlm.nih.gov/pubmed/30887755
http://dx.doi.org/10.3802/jgo.2019.30.e32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424844/
https://www.ncbi.nlm.nih.gov/pubmed/30887755
http://dx.doi.org/10.3802/jgo.2019.30.e32

Ejemplares similares